Loading
Taxanes lift the nail from its bed, leave transverse ridges that mark each cycle, and discolour it. Reported rates across studies range from none to forty-four per cent. Cooling the hands during the infusion reduced nail damage in a pooled analysis, but the one properly randomised trial was negative and six in ten participants stopped because the cold was too uncomfortable.
The pattern is well described: nail pigmentation, bleeding under the nail, Beau's lines, which are transverse grooves marking each chemotherapy cycle, and onycholysis, the nail separating from its bed. The reference series describing it reviewed the literature and reported an incidence "ranging from 0% to 44%", a spread that says more about how it is measured than about how often it happens.
One pattern is specific and avoidable. In a series of 91 patients given paclitaxel, onycholysis occurred in 5 of 21 who received more than six weekly courses, "developing in the summer months in all 5 patients", and in none of those treated every three weeks or in 187 patients given doxorubicin. The authors' conclusion is a piece of practical advice that costs nothing: "Patients receiving these drugs should protect their nails from sunlight."
Cooling the hands during the infusion is the main preventive measure and its evidence is mixed. The widely cited frozen-glove study was not randomised: each patient wore the glove on the right hand and the left acted as the control, and onycholysis was grade 0 in 89 per cent of protected hands against 49 per cent of control hands. The randomised trial of the same idea, where the gloved hand was allocated at random, found "no significant differences" between hands and had a 60 per cent withdrawal rate "due to patient discomfort with the intervention". A meta-analysis pooling three randomised and six prospective studies in 708 patients found total nail toxicity lower with cryotherapy (risk ratio 0.49, 95 per cent confidence interval 0.30 to 0.79), although the confidence interval for grade 2 to 3 toxicity crossed one.
One thing to avoid: in a randomised trial of 105 women comparing specialist nail drops, nail polish and standard care, "less nail toxicity was observed in patients receiving specialist nail drops or standard care arms in comparison to those using nail polish".
What comes back, and when: nails grow out, a fingernail taking roughly six months and a toenail twelve to eighteen, so the ridges and discolouration move up the nail and are eventually cut off. OnCo could not find a primary source reporting the proportion in whom nails return to normal, or how long that takes, so that figure is a named gap here rather than a number.
The nail matrix is a rapidly dividing epithelium, so a cytotoxic pulse interrupts plate formation and leaves a groove corresponding in position to the timing of the cycle. Taxanes additionally affect the nail bed vasculature, producing haemorrhage and separation, and photosensitivity explains the weekly-paclitaxel summer pattern. Cooling reduces blood flow and therefore drug delivery to the matrix during the infusion peak.
Query for this technology: (TITLE:"Nails after chemotherapy: lifting, ridges and discolouration" OR ABSTRACT:"Nails after chemotherapy: lifting, ridges and discolouration") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Nails after chemotherapy: lifting, ridges and discolouration, not a curated reading list.
Shares Frozen gloves, socks and compression for taxane nail and nerve damage, Late effects and survivorship toxicity, Docetaxel, Toxicity and quality of life are undervalued and the tags rejuvenation, survivorship.
Shares Late effects and survivorship toxicity, Toxicity and quality of life are undervalued, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags rejuvenation, survivorship.
Shares Late effects and survivorship toxicity, Toxicity and quality of life are undervalued, Ovarian cancer, Triple-negative breast cancer (TNBC) and the tags rejuvenation, survivorship.
Shares Late effects and survivorship toxicity, Toxicity and quality of life are undervalued, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags rejuvenation, survivorship.
Shares Late effects and survivorship toxicity, Toxicity and quality of life are undervalued, Ovarian cancer, Cytotoxic chemotherapy and the tags rejuvenation, survivorship.
Shares Toxicity and quality of life are undervalued, Paclitaxel / nab-paclitaxel, HR-positive / HER2-negative breast cancer and the tags rejuvenation, survivorship.
Shares Late effects and survivorship toxicity, Toxicity and quality of life are undervalued, HR-positive / HER2-negative breast cancer, Prostate cancer and the tags rejuvenation, survivorship.
Shares Late effects and survivorship toxicity, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags rejuvenation, survivorship.